This is a new initiative to support MD postdoctoral fellows in a four year clinical pharmacology training program at Johns Hopkins. It is designed to address the widely-recognized shortage of rigorously trained physician scientists who conduct hands-on studies in humans, particularly in the area of clinical pharmacology. The program is centered in the Division of Clinical Pharmacology, a unit jointly under the Department of Medicine and the Department of Pharmacology and Molecular Sciences, in the School of Medicine. Recent leadership changes in both parent Departments and in the Division itself afford exciting new opportunities to formalize a training program that directly links molecular and clinical sciences. The proposed four year program includes a one year core curriculum in clinical pharmacology (coursework plus three research rotations) followed by three years of thesis research in the PHD-granting Graduate Training Program in Clinical Investigation. Thesis projects will include a molecular as well as a clinical component, a model used successfully with past and current trainees in the Division. Based on the collective expertise of the existing Division faculty, research is likely to focus on some aspect of anti-infective drugs, with a new emphasis on anti-parasitic agents. Each trainee will have a Primary' Mentor who will oversee the clinical aspects of the research project, complemented when appropriate by a Co-Mentor with expertise in basic science. The participating faculty includes not only those currently in the Division of Clinical Pharmacology but also a group chosen to reflect ongoing or foreseeable research collaborations and important teaching associations. The program will benefit from the advice and oversight of an Advisory Board comprised of distinguished clinician-scientists from within and outside of Johns Hopkins. Graduates from this program will have the skills and knowledge to undertake an independent career that features research in both basic and clinical pharmacology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
1T32GM066691-01
Application #
6554473
Study Section
Special Emphasis Panel (ZGM1-BRT-2 (PD))
Program Officer
Okita, Richard T
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$141,029
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Weld, Ethel D; Dooley, Kelly E (2018) State-of-the-Art Review of HIV-TB Coinfection in Special Populations. Clin Pharmacol Ther 104:1098-1109
Ippolito, Matthew M; Denny, Joshua E; Langelier, Charles et al. (2018) Malaria and the Microbiome: A Systematic Review. Clin Infect Dis 67:1831-1839
Ippolito, Matthew M; Kamavu, Luc K; Kabuya, Jean-Bertin et al. (2018) Risk Factors for Mortality in Children Hospitalized with Severe Malaria in Northern Zambia: A Retrospective Case-Control Study. Am J Trop Med Hyg 98:1699-1704
Eke, Ahizechukwu C; McCormack, Shelley A; Best, Brookie M et al. (2018) Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. J Clin Pharmacol :
Ippolito, Matthew M; Jacobson, Jeffrey M; Lederman, Michael M et al. (2018) Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquine. Clin Infect Dis 67:1617-1620
Seddon, J A; Weld, E D; Schaaf, H S et al. (2018) Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done? Int J Tuberc Lung Dis 22:24-33
Aung, Wutyi S; Bakshi, Rahul P; Breakey, Jennifer et al. (2018) Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies. AIDS Behav :
Robinson, Jennifer A; Marzinke, Mark A; Fuchs, Edward J et al. (2018) Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05). J Acquir Immune Defic Syndr 77:175-182
Bakshi, Rahul P; Tatham, Lee M; Savage, Alison C et al. (2018) Long-acting injectable atovaquone nanomedicines for malaria prophylaxis. Nat Commun 9:315
Eke, Ahizechukwu C; Chakhtoura, Nahida; Kashuba, Angela et al. (2018) Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. J Acquir Immune Defic Syndr 78:308-313

Showing the most recent 10 out of 62 publications